Focusing on the second phase of plasma HIV-1 RNA clearance. - Suppr | 超能文献

Focusing on the second phase of plasma HIV-1 RNA clearance.

作者信息

Lafeuillade A, Poggi C, Sayada C, Pellegrino P, Profizi N

出版信息

AIDS. 1997 Feb;11(2):264-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Focusing on the second phase of plasma HIV-1 RNA clearance.

AIDS. 1997 Feb;11(2):264-6.

2

Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.ALBI试验结果：对初治抗逆转录病毒治疗患者中司他夫定/去羟肌苷、齐多夫定/拉米夫定及交替治疗的随机对照比较

Antivir Ther. 1999;4 Suppl 3:71-4.

3

The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.ALBI试验：一项随机对照试验，比较司他夫定加去羟肌苷与齐多夫定加拉米夫定，以及在既往未接受治疗的人类免疫缺陷病毒感染患者中交替使用这两种组合的方案。

J Infect Dis. 1999 Aug;180(2):351-8. doi: 10.1086/314891.

4

AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.阿凡提2. 一项随机、双盲试验，旨在评估齐多夫定加拉米夫定与齐多夫定加拉米夫定加茚地那韦在未接受过抗逆转录病毒治疗的HIV感染患者中的疗效和安全性。

AIDS. 2000 Mar 10;14(4):367-74.

5

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.洛匹那韦/利托那韦单药治疗或联合齐多夫定和拉米夫定用于初治的HIV感染患者。

AIDS. 2008 Jan 30;22(3):385-93. doi: 10.1097/QAD.0b013e3282f3f16d.

6

Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patients.M184V突变对核苷类逆转录酶抑制剂经治患者换用去羟肌苷或维持拉米夫定治疗的临床影响。

J Infect Dis. 2003 Aug 15;188(4):537-40. doi: 10.1086/377742. Epub 2003 Jul 24.

7

[HIV infection: DuPont Pharma presents the results of its antiretroviral agent].[HIV感染：杜邦制药公布其抗逆转录病毒药物的研究结果]

Allerg Immunol (Paris). 1998 Apr;30(4):123-4.

8

Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.替诺福韦：新适应症。用于一线抗逆转录病毒治疗：观望。

Prescrire Int. 2004 Oct;13(73):180-2.

9

Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.安普那韦联合拉米夫定和齐多夫定与拉米夫定和齐多夫定单药治疗初治的HIV-1感染成人的疗效比较。安普那韦PROAB3001国际研究团队。

Antivir Ther. 2000 Sep;5(3):215-25.

10

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.齐多夫定耐药突变对齐多夫定-拉米夫定-利托那韦治疗病毒学反应的影响：来自艾滋病临床试验组方案315的1型人类免疫缺陷病毒分离株的基因分型分析。艾滋病临床试验组方案315团队。

J Infect Dis. 2000 Feb;181(2):491-7. doi: 10.1086/315244.

引用本文的文献

1

Correlation between the Biodistribution of Bovine Leukemia Virus in the Organs and the Proviral Load in the Peripheral Blood during Early Stages of Experimentally Infected Cattle.实验感染牛早期阶段器官中牛白血病病毒的生物分布与外周血前病毒载量之间的相关性

Pathogens. 2023 Jan 12;12(1):130. doi: 10.3390/pathogens12010130.

2

Virus dynamics and drug therapy.病毒动力学与药物治疗

Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6971-6. doi: 10.1073/pnas.94.13.6971.